Fundraising Fox

Kidney

6 known investors

The National Kidney Foundation works to eliminate preventable kidney disease, accelerate innovation in patient care, and address structural inequities in kidney treatment and transplantation services. The organization serves patients with kidney disease and at-risk communities.

HealthtechImpact & Social Good

Investors · 6

Ysios CapitalBarcelona · $5.4M – $21.6M
BioGeneration VenturesreportedNaarden
Epidarex CapitalreportedBethesda · $2.5M – $6.3M
Roche Venture FundreportedBasel · $648K – $3.2M
Scottish National Investment BankreportedEdinburgh · $1.3M
Sofinnova PartnersreportedParis · $540K – $27M

Funding

SEC filings, press & company announcements

$43.5M disclosed across 1 round · 2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Glasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment | EU-Startupseu-startups.com · Aug 2026Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney diseasestreetinsider.com · Aug 2026Kidney-related provisions in the 2026 government funding law | American Kidney Fundkidneyfund.org · Feb 2026Federal Investment | National Kidney Foundationkidney.org

Frequently asked questions

What does Kidney do?
The National Kidney Foundation works to eliminate preventable kidney disease, accelerate innovation in patient care, and address structural inequities in kidney treatment and transplantation services. The organization serves patients with kidney disease and at-risk communities.
Who are Kidney's investors?
Kidney's investors include Ysios Capital, BioGeneration Ventures, Epidarex Capital, Roche Venture Fund, Scottish National Investment Bank, Sofinnova Partners.
How much funding has Kidney raised?
Kidney has disclosed $43.5M raised across 1 round.